Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines

Julia M.L. Brotherton; Mark Jit; Patti E. Gravitt; Marc Brisson; Aimée R. Kreimer; Sara I. Pai; Carole Fakhry; Joseph Monsonego; Silvia Franceschi

doi:10.1002/ijc.30063

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines

Julia M.L. Brotherton, Mark Jit, Patti E. Gravitt, Marc Brisson, Aimée R. Kreimer, Sara I. Pai, Carole Fakhry, Joseph Monsonego, Silvia Franceschi

Global Public Health

Research output: Contribution to journal › Review article › peer-review

Abstract

This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority research areas.

Original language	English (US)
Pages (from-to)	510-517
Number of pages	8
Journal	International Journal of Cancer
Volume	139
Issue number	3
DOIs	https://doi.org/10.1002/ijc.30063
State	Published - Aug 1 2016

Keywords

cervical cancer
HPV
oropharyngeal cancer
vaccine

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/ijc.30063

Cite this

@article{367db3fdde2b4bce97413cf8917d1c6f,

title = "Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines",

abstract = "This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority research areas.",

keywords = "cervical cancer, HPV, oropharyngeal cancer, vaccine",

author = "Brotherton, {Julia M.L.} and Mark Jit and Gravitt, {Patti E.} and Marc Brisson and Kreimer, {Aim{\'e}e R.} and Pai, {Sara I.} and Carole Fakhry and Joseph Monsonego and Silvia Franceschi",

note = "Publisher Copyright: {\textcopyright} 2016 UICC.",

year = "2016",

month = aug,

day = "1",

doi = "10.1002/ijc.30063",

language = "English (US)",

volume = "139",

pages = "510--517",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Eurogin Roadmap 2015

T2 - How has HPV knowledge changed our practice: Vaccines

AU - Brotherton, Julia M.L.

AU - Jit, Mark

AU - Gravitt, Patti E.

AU - Brisson, Marc

AU - Kreimer, Aimée R.

AU - Pai, Sara I.

AU - Fakhry, Carole

AU - Monsonego, Joseph

AU - Franceschi, Silvia

PY - 2016/8/1

Y1 - 2016/8/1

N2 - This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority research areas.

AB - This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority research areas.

KW - cervical cancer

KW - HPV

KW - oropharyngeal cancer

KW - vaccine

UR - http://www.scopus.com/inward/record.url?scp=84967189749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84967189749&partnerID=8YFLogxK

U2 - 10.1002/ijc.30063

DO - 10.1002/ijc.30063

M3 - Review article

C2 - 26916230

AN - SCOPUS:84967189749

SN - 0020-7136

VL - 139

SP - 510

EP - 517

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 3

ER -

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this